Development of Mesophasic Microreservoir-Based Transdermal Drug Delivery System of Propranolol
2008

Transdermal Drug Delivery System of Propranolol

publication Evidence: moderate

Author Information

Author(s): Omray L. K., Kohli S., Khopade A. J., Patil S., Gajbhiye Asmita, Agrawal G. P.

Primary Institution: Guru Ramdas Khalsa Institute of Science and Technology (Pharmacy), Barela, Jabalpur-483 001, India

Hypothesis

The study aimed to develop a mesophasic microreservoir-based transdermal drug delivery system for propranolol.

Conclusion

The mesophasic microreservoir-based transdermal systems are stable, easy to prepare, and can effectively deliver propranolol for treating hypertension.

Supporting Evidence

  • The liquid crystalline phase is thermodynamically stable and can be stored unchanged for long periods.
  • Controlled release of propranolol was observed over 24 hours from the developed systems.
  • Entrapment efficiency of the liquid crystals was found to be 94±2.5%.

Takeaway

This study created a new way to deliver a medicine called propranolol through the skin, which can help people with high blood pressure.

Methodology

The study involved preparing liquid crystals and a transdermal patch, followed by evaluating their properties such as drug release and stability.

Digital Object Identifier (DOI)

10.4103/0250-474X.45394

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication